Clarifying values: An updated review.
BMC Medical Informatics and Decision Making.
Times cited: 52
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Journal of Clinical Oncology.
Times cited: 169